Smith Rebecca M, Burgess Caroline, Beattie Jenna, Newdick Abby, Tahtis Vassilios, Sahu Bithi, Golding John F, Marsden Jonathan, Seemungal Barry M
Centre for Vestibular Neurology, Department of Brain Sciences, Imperial College London, London, UK.
School of Population Health & Environmental Studies, King's College London, London, UK.
BMJ Neurol Open. 2024 May 28;6(1):e000598. doi: 10.1136/bmjno-2023-000598. eCollection 2024.
Benign paroxysmal positional vertigo (BPPV) affects approximately half of acute, moderate-severe traumatic brain injury (TBI) patients. To date, there have been no rigorous studies of BPPV assessment or treatment in this cohort. We aimed to determine the safety, practicability, and efficacy of therapist-led BPPV management in acute TBI and the feasibility of a larger effectiveness trial.
This was a multi-centre, three-arm, parallel-groups, randomised, feasibility trial. Recruitment was via convenience sampling. The main inclusion criteria were age over 18 years and a confirmed, non-penetrating, acute TBI. BPPV-positive patients were randomly allocated to one of three interventions (repositioning manoeuvres, Brandt-Daroff exercises or advice) using minimisation criteria. Outcome assessors were blinded to the intervention.
Of 2014 patients screened for inclusion, 180 were assessed for BPPV. Of those assessed, 34% (62/180) had BPPV, and 58 patients received an intervention. Therapist-led interventions were delivered safely and accurately according to intervention monitoring criteria. Resolution of BPPV was observed in 35/58 (60%) patients. The resolution rate was highest following repositioning manoeuvres (78%), followed by the advice (53%) and Brandt-Daroff interventions (42%). 10 patients experienced recurrence. This was observed more frequently in those with skull fractures and bilateral or mixed BPPV.
Overall, the results provide strong evidence for the feasibility of a future trial. Therapist-led management of BPPV in acute TBI was safe and practicable. Repositioning manoeuvres seemingly yielded a superior treatment effect. However, given the high recurrence rate of post-traumatic BPPV, the optimal time to treat according to patients' specific recurrence risk requires further investigation.
ISRCTN91943864, https://doi.org/10.1186/ISRCTN91943864.
良性阵发性位置性眩晕(BPPV)影响约一半的急性中重度创伤性脑损伤(TBI)患者。迄今为止,尚未对该队列中的BPPV评估或治疗进行严格研究。我们旨在确定治疗师主导的BPPV管理在急性TBI中的安全性、实用性和有效性,以及更大规模有效性试验的可行性。
这是一项多中心、三臂、平行组、随机可行性试验。通过便利抽样进行招募。主要纳入标准为年龄超过18岁且确诊为非穿透性急性TBI。使用最小化标准将BPPV阳性患者随机分配至三种干预措施之一(复位手法、Brandt-Daroff训练或建议)。结果评估者对干预措施不知情。
在筛查纳入的2014例患者中,180例接受了BPPV评估。在这些接受评估的患者中,34%(62/180)患有BPPV,58例患者接受了干预。根据干预监测标准,治疗师主导的干预措施安全且准确地实施。58例患者中有35例(60%)的BPPV得到缓解。复位手法后的缓解率最高(78%),其次是建议(53%)和Brandt-Daroff干预(42%)。10例患者出现复发。在颅骨骨折以及双侧或混合性BPPV患者中复发更为常见。
总体而言,研究结果为未来试验的可行性提供了有力证据。治疗师主导的急性TBI患者BPPV管理安全且可行。复位手法似乎产生了更好的治疗效果。然而,鉴于创伤后BPPV的高复发率,根据患者的特定复发风险确定最佳治疗时间需要进一步研究。
ISRCTN91943864,https://doi.org/10.1186/ISRCTN91943864 。